Medical AI Alliance
← Company Index
Biotech & Drug DiscoveryKOSPI 007570493 approvals45 trials

ILYANG PHARMACEUTICAL CO.,LTD

Official website

KOSPI-listed pharmaceutical company known for its anti-ulcer drug Noltec and leukemia treatment Supect (radotinib).

As of 2026-10-10, ILYANG PHARMACEUTICAL CO.,LTD has 7 Korean MFDS device approvals, 486 Korean MFDS drug approvals, 11 PubMed-indexed papers on record (counted by the MAA Company Index from its own matching of public databases).

Price

Change

Market cap

Business overview

Source: DART corporate disclosure

Founded in 1946 and listed on KOSPI in 1974, Ilyang Pharmaceutical is a diversified pharmaceutical company. Its main products are Noltec, Korea's 14th approved new drug, an anti-ulcer treatment for gastric ulcer and GERD, and Supect (radotinib), Korea's 18th approved new drug, a CML leukemia treatment approved as a first-line therapy in October 2015, alongside the P-CAB class gastric acid suppressant candidate IY-828026 and the quadrivalent influenza vaccine Theratect prefilled syringe. Its 55th-term consolidated revenue was KRW 272.4 billion, with operating profit of KRW 4.9 billion and net income of KRW 7.1 billion, and Supect was out-licensed to China's Yangzhou Ilyang Pharmaceutical Co., Ltd. in 2013, completing local Phase 3 trials and an NDA filing.

Products & technology

  • NoltecAnti-ulcer drug for duodenal/gastric ulcer, GERD, and H. pylori eradication therapy
  • Noltec PlusNoltec-antacid combination formulation
  • Supect (radotinib)Leukemia (CML) treatment
  • Theratect prefilled syringeQuadrivalent influenza vaccine
  • Ilyang Flu Vaccine prefilled syringeTrivalent influenza vaccine

Regulatory approvals

data.go.kr

486 Korean MFDS drug approvals · 1966–2026 / 7 Korean MFDS device approvals · 1997–2016

  • MFDS drugNOLTEC PLUS MINI Tab. 10/250mg2026-09-30
    Drug · Prescription · Approval202602946
  • MFDS drugSubsidiary: 일양바이오팜Allercap Zero Tab. 120mg2026-09-28
    Drug · OTC · Notification202602898
  • MFDS drugIlyang D-Panthenol Ointment2026-08-28
    Drug · OTC · Notification202602531
  • MFDS drugvopcab tab. 10mg2026-08-24
    Drug · Prescription · Approval202602451
  • MFDS drugvopcab Tab. 20mg2026-08-24
    Drug · Prescription · Approval202602452
  • MFDS drugCrego Duo ODT 10/5mg2026-06-30
    Drug · Prescription · Approval202601876
  • MFDS drugCrego Duo ODT 10/10mg2026-06-30
    Drug · Prescription · Approval202601877
  • MFDS drugCrego Duo ODT 10/20mg2026-06-30
    Drug · Prescription · Approval202601878
  • MFDS drugMagric Calcon Speed Solution2026-05-27
    Drug · OTC · Notification202601535
  • MFDS drugIlyang Famotidine Tab.2026-05-08
    Drug · OTC · Notification202601351
  • MFDS drugBurmooden S Gel2026-04-20
    Drug · OTC · Notification202601137
  • MFDS drugSokco zero cap.2026-04-15
    Drug · OTC · Notification202601088
Show 68 more
  • MFDS drugTriplelow Tab 40/5/12.5mg2026-04-08
    Drug · Prescription · Approval202600996
  • MFDS drugTriplelow Tab 80/5/25mg2026-04-08
    Drug · Prescription · Approval202600997
  • MFDS drugTriplelow Tab 80/5/12.5mg2026-04-08
    Drug · Prescription · Approval202600998
  • MFDS drugIL-YANG KiWhang Solution2026-03-20
    Drug · OTC · Notification202600803
  • MFDS drugIlyang Vita Won Sol.2026-02-19
    Drug · OTC · Notification202600442
  • MFDS drugSubsidiary: 일양바이오팜Ilyang Bio mag Solution2026-02-19
    Drug · OTC · Notification202600458
  • MFDS drugIL-YANG WONBI Oral Liquid2026-01-28
    Drug · OTC · Approval202600235
  • MFDS drugIL-YANG WON Oral Liquid2026-01-28
    Drug · OTC · Approval202600236
  • MFDS drugSubsidiary: 일양바이오팜Loperinol A Cap.2026-01-07
    Drug · OTC · Notification202600047
  • MFDS drugIlyang Mag Z tab.2025-12-22
    Drug · OTC · Notification202503336
  • MFDS drugCleanTokTokB Nasal Spray2025-11-10
    Drug · OTC · Notification202502900
  • MFDS drugAlled Zero Tab. 180mg2025-10-17
    Drug · Prescription · Approval202502697
  • MFDS drugWonbi-D S Sol.2025-09-01
    Drug · OTC · Notification202502291
  • MFDS drugLactodearophen Tab2025-08-05
    Drug · OTC · Notification202502036
  • MFDS drugWizero Alfa Powder2025-06-19
    Drug · OTC · Notification202501520
  • MFDS drugIlyang Three Sok Tab.2025-04-30
    Drug · OTC · Notification202501043
  • MFDS drugJoinup double Plaster2025-04-15
    Drug · OTC · Notification202500910
  • MFDS drugNOLTEC PLUS Tab. 20/500mg2025-03-04
    Drug · Prescription · Approval202500485
  • MFDS drugNuneTop F Soft Cap.2025-02-28
    Drug · OTC · Notification202500464
  • MFDS drugAlled Zero Tab. 120mg2025-02-07
    Drug · OTC · Notification202500268
  • MFDS drugWizero Yukwae Soft Ext.2024-11-19
    Drug · OTC · Notification202402724
  • MFDS drugpamixbio Ginkgo Tab.2024-11-06
    Drug · OTC · Notification202402625
  • MFDS drugMeco Mg Premium Tab.2024-10-23
    Drug · OTC · Notification202402513
  • MFDS drugSubsidiary: 일양바이오팜BraGinko Tab. 240mg2024-10-08
    Drug · OTC · Notification202402394
  • MFDS drugTitano A Ointment2024-08-27
    Drug · OTC · Notification202402067
  • MFDS drugSubsidiary: 일양바이오팜Morning Tok F Enteric Coated Soft Cap.2024-08-14
    Drug · OTC · Notification202401985
  • MFDS drugAzinpamK Tab.2024-05-31
    Drug · OTC · Notification202401358
  • MFDS drugMeco Mg Premium Tab.Revoked2024-05-27
    Drug · OTC · Notification202401289
  • MFDS drugMian Toktok Eye Drops2024-04-29
    Drug · OTC · Notification202401031
  • MFDS drugSubsidiary: 일양바이오팜Tongcare Tab2024-04-22
    Drug · OTC · Notification202400918
  • MFDS drugJang Zero Q Enteric Coated Tab.2024-03-29
    Drug · OTC · Notification202400705
  • MFDS drugFreenose S Tab.2024-03-26
    Drug · OTC · Notification202400648
  • MFDS drugChroazone N Tab.2024-03-26
    Drug · OTC · Notification202400654
  • MFDS drugJang Zero S Granule2024-03-21
    Drug · OTC · Notification202400585
  • MFDS drugIlyang Care Nail Lacquer2024-03-14
    Drug · OTC · Notification202400541
  • MFDS drugAzinpamQ Tab.2024-02-22
    Drug · OTC · Notification202400385
  • MFDS drugTwoB-Beta Sol.2024-02-14
    Drug · OTC · Notification202400325
  • MFDS drugMulti Sok Tab.2024-01-23
    Drug · OTC · Notification202400177
  • MFDS drugSubsidiary: 일양바이오팜Mahaphen Tab. 500mg2024-01-22
    Drug · OTC · Notification202400157
  • MFDS drugWonbi-D Gold Sol.Revoked2024-01-04
    Drug · OTC · Notification202400029
  • MFDS drugTERATECT Vaccine INJ.2024-01-04
    Drug · Prescription · Approval202400021
  • MFDS drugCaneclo Vagina. Tab.2023-12-05
    Drug · OTC · Notification202303278
  • MFDS drugSpamac S Tab.2023-11-16
    Drug · OTC · Notification202303159
  • MFDS drugBonaling speed sol.2023-10-04
    Drug · OTC · Notification202302853
  • MFDS drugBenfovitanice Tab.2023-09-06
    Drug · OTC · Notification202302654
  • MFDS drugCoQ10 Vitaalbu X tab.2023-08-30
    Drug · OTC · Notification202302576
  • MFDS drugIdiance Duo Tab. 12.5/1000mg2023-08-30
    Drug · Prescription · Approval202302577
  • MFDS drugIdiance Duo Tab. 12.5/850mg2023-08-30
    Drug · Prescription · Approval202302578
  • MFDS drugIdiance Duo Tab. 12.5/500mg2023-08-30
    Drug · Prescription · Approval202302579
  • MFDS drugSubsidiary: 일양바이오팜Jointcombi 800 Tab2023-08-29
    Drug · OTC · Notification202302546
  • MFDS drugDiochimin Tab.(Diosmin)2023-07-03
    Drug · OTC · Notification202302041
  • MFDS drugDapaige ER Tab. 10/500mg2023-06-21
    Drug · Prescription · Approval202301894
  • MFDS drugSokcol syrup2023-03-21
    Drug · OTC · Notification202300978
  • MFDS drugIlyang acetaminophen syrup2023-02-20
    Drug · OTC · Notification202300632
  • MFDS drugSpantec Sublingual Tab.(Phloroglucinol Hydrate)2023-01-26
    Drug · Prescription · Approval202300345
  • MFDS drugDapaige ER Tab. 10/1000mg2023-01-06
    Drug · Prescription · Approval202300144
  • MFDS drugSokcol cool Powder2022-11-28
    Drug · OTC · Notification202204271
  • MFDS drugIlyang Dapame XR Tab. 5/500mg2022-11-10
    Drug · Prescription · Approval202204067
  • MFDS drugIlyang Dapame XR Tab. 10/500mgRevoked2022-11-10
    Drug · Prescription · Approval202204068
  • MFDS drugIlyang Chungshim Sol.2022-10-19
    Drug · OTC · Notification202203867
  • MFDS drugIlyang Galgeuntang Sol.2022-07-20
    Drug · OTC · Notification202202997
  • MFDS drugIlyang Socheongryongtang Sol.2022-07-20
    Drug · OTC · Notification202202998
  • MFDS drugIlyang Samsoeum Sol.2022-07-19
    Drug · OTC · Notification202202970
  • MFDS drugIlyang Ssangwhatang Sol.2022-07-19
    Drug · OTC · Notification202202971
  • MFDS drugWizero alfa Tab.2022-07-15
    Drug · OTC · Notification202202909
  • MFDS drugtoamin inj. 3%2022-06-08
    Drug · Prescription · Notification202202374
  • MFDS drugDodamdodam Triple Vita Sol.2022-04-26
    Drug · OTC · Notification202201698
  • MFDS drugIdiance Duo Tab. 5/850mg2022-04-04
    Drug · Prescription · Approval202201336

Showing the 80 most recent of 493 records.

Clinical trials

data.go.kr

45 MFDS clinical trial authorisations · 2012–2026 (Phase 1 22 · Phase 3 12 · Bioequivalence 10 · Phase 1/2a 1)

  • Phase 3UROCOM-R1, UROCOM-R22026-09-03

    15 trial sites

  • Phase 1IY-8280262025-12-29

    1 trial site

  • Phase 1UROCOM-R1, UROCOM-R22025-09-12

    1 trial site

  • Phase 1IY-1149DO-T2024-11-29

    2 trial sites

  • Phase 1슈펙트캡슐(라도티닙염산염)2024-06-27

    2 trial sites

  • Phase 1IY-HCR212024-04-09

    2 trial sites

  • Phase 3놀텍정10mg(일라프라졸)2024-01-18

    13 trial sites

  • Phase 1IY-NS2502024-01-02

    2 trial sites

  • Phase 3일양플루백신4가주(인플루엔자분할백신)2023-12-21

    12 trial sites

  • Phase 1IY-1149DO-T2022-09-21

    2 trial sites

  • Phase 1놀텍정10mg(일라프라졸)2022-08-26

    1 trial site

  • Phase 1IY-1149DO-T2022-06-24

    2 trial sites

Show 33 more
  • Phase 1IY-HCR212022-05-26

    2 trial sites

  • Bioequivalence요시케어정10밀리그램(솔리페나신숙신산염)2022-04-07

    2 trial sites

  • Bioequivalence일양클로피도그렐정75밀리그램(클로피도그렐황산염)2021-12-14

    2 trial sites

  • Phase 1놀텍정10mg(일라프라졸)2021-10-28

    1 trial site

  • Phase 1IY-IC0622021-10-13

    2 trial sites

  • Phase 3일양플루백신4가주(인플루엔자분할백신)2020-03-03

    10 trial sites

  • Phase 1IYV70022020-02-28
  • Phase 1IY-HCR172018-09-04

    1 trial site

  • Phase 1IY-HCR172018-08-27

    1 trial site

  • Phase 3놀텍정10mg(일라프라졸)2018-02-20

    8 trial sites

  • Phase 3슈펙트캡슐(라도티닙염산염)2018-02-19

    22 trial sites

  • Phase 3일양플루백신4가주(인플루엔자분할백신)2017-06-21

    16 trial sites

  • Bioequivalence후릭스정(푸로세미드)2016-11-25

    2 trial sites

  • Phase 1놀텍정10mg(일라프라졸)2016-11-10

    1 trial site

  • Phase 1IYV70012016-10-26

    1 trial site

  • Bioequivalence일양디세텔정(피나베륨브롬화물)2016-10-19

    2 trial sites

  • Bioequivalence하이네콜정(베타네콜염화물)2016-10-17

    2 trial sites

  • Phase 3일양플루백신4가주(인플루엔자분할백신)2015-10-21

    16 trial sites

  • Bioequivalence플루렉스캡슐75밀리그램(인산오셀타미비르)2015-09-10

    2 trial sites

  • Bioequivalence일양레바미피드정2015-08-07

    2 trial sites

  • Phase 1/2a일양플루백신4가주(인플루엔자분할백신)2015-01-29

    1 trial site

  • Bioequivalence인다팜정(인다파미드)2014-02-05

    2 trial sites

  • Phase 3일양플루백신주(인플루엔자분할백신)2013-10-18

    13 trial sites

  • Bioequivalence일양로자탄플러스에프정2013-03-05

    2 trial sites

  • Phase 1일양플루백신주(인플루엔자분할백신)2013-01-24

    1 trial site

  • Phase 3일양플루백신주(인플루엔자분할백신)2012-11-22

    10 trial sites

  • Phase 1일양플루백신주(인플루엔자분할백신)2012-09-14

    1 trial site

  • Phase 3놀텍정10mg(일라프라졸)2012-09-03

    16 trial sites

  • Bioequivalence듀얼다운정10/160밀리그램2012-08-29

    2 trial sites

  • Phase 1놀텍정10mg(일라프라졸)2012-06-12
  • Phase 3놀텍정10mg(일라프라졸)2012-06-11

    13 trial sites

  • Phase 1놀텍정10mg(일라프라졸)2012-04-13

    1 trial site

  • Phase 1놀텍정10mg(일라프라졸)2012-04-12

    1 trial site

Global clinical trials

ClinicalTrials.gov · sponsor-matched
Show 23 more trials

R&D and key agreements

Source: DART corporate disclosure

슈펙트(라도티닙) 2차치료제 적응증 · 만성골수성백혈병(CML) 2차치료제 · 다국가(4개국) 임상3상 진행중

슈펙트 파킨슨병 적응증 · 파킨슨병 · 프랑스 임상2상 진행중(IND승인 완료)

IY-828026 · 위산분비 관련질환 · 임상1상 진행중 · P-CAB class gastric acid suppressant candidate

비뇨기 복합제 개량신약 · 비뇨기질환 · 임상1상 진행중

놀텍 NSAIDs 병용 적응증 확대 · 임상1상 완료, 임상3상 진행중

Key disclosures

KRX KIND via OpenDART

Publications

PubMed · affiliation-matched
Show 1 more publications

Patents

KIPRIS · applicant-matched
Show 148 more patents

AI reads

MAA server logs · IP-verified
85
Times AI engines pulled ILYANG PHARMACEUTICAL CO.,LTD's records

Pulled records become part of each AI's index and keep feeding its answers. When an AI cites from that index, nothing reaches our server — so actual citations are uncounted here and exceed this number.

1
Fetched fresh mid-answer

Times an AI needed something not yet in its index and fetched this page fresh while answering. Citations served from the index leave no trace here.

84
Index crawls

Collected as raw material for future answers.

0
Direct AI-tool queries (MCP)

Queries from users who connected this index to their own AI.

12
live 1
Last 7 days
63
live 1
Last 30 days
85
live 1
All time
  • OpenAIChatGPT-Userlive1
  • OpenAIOAI-SearchBot75
  • PerplexityPerplexityBot3
  • GoogleGoogleOther3
  • AnthropicClaudeBot2
  • MicrosoftBingbot1

Measured since Aug 27, 2026 · 5 AI engines · last read Oct 10, 2026

User-agent strings can be forged, so we do not count them at face value. We count only requests matched against vendor-published IP ranges, or confirmed by forward-verified reverse DNS. MCP queries are actual calls to this index's tool endpoint.

Connect this index to your AI tool →

Connect this company index directly to your AI

Connect it to ChatGPT or Claude, and your AI queries the full record — profiles, financials, stock data, regulatory approvals, clinical trials, publications and patents — for ILYANG PHARMACEUTICAL CO.,LTD and every listed Korean medical, bio and AI company.

How to connect (MCP)
Not yet compiled: business overview. Send us materials and we will add them

Companies approved for the same productsBiotech & Drug Discovery

Ranked by how many MFDS product categories overlap. Not a ranking — a pointer to where to look.

OSANG HEALTHCARE CO.,LTD.2 shared

Founded 1996, listed on KOSDAQ in 2024, OSANG HEALTHCARE develops and sells biochemistry, immunodiagnostic, and molecular IVD products.

Hanmi Pharm. Co., Ltd.1 shared

KOSPI-listed pharmaceutical company behind the combination drugs Amosartan (hypertension) and Rosuzet (dyslipidemia).

KOREAN DRUG CO., LTD.1 shared

Founded in 1980, Korean Drug produces the cold medicine Haben and the dementia drug Neuromed, along with other CNS disease treatments.

KYUNG NAM PHARM.CO.,LTD.1 shared

Founded in 1998, Kyungnam Pharm is a pharmaceutical and health-food company known for the vitamin brand Lemona and placenta drink Jahasaengryeok.

SINSIN PHARMACEUTICAL Co., LTD.1 shared

Sinsin Pharmaceutical sells medicated patches and OTC medicines through direct deals with over 13,000 pharmacies nationwide.

Aprogen Biologics Inc.1 shared

Aprogen Biologics develops Remicade, Rituxan, and Herceptin biosimilars and operates a world top-5 scale antibody production facility.

ChoA Pharmaceutical Co., LTD.1 shared

Founded in 1996 and listed on KOSDAQ in 1999, ChoA Pharmaceutical is an OTC-focused drugmaker exporting to 23 countries worldwide.

CALTH. Inc1 shared

Holds manufacturing approvals for 42 point-of-care diagnostic reagents and devices in the IVD market.

IL DONG PHARMACEUTICAL CO., LTD.1 shared

Founded and listed on the KOSPI in 2016, Il Dong Pharmaceutical manufactures products including the Aronamin vitamin line.

DONG-A ST CO.,LTD1 shared

Dong-A ST, spun off from Dong-A Socio Holdings in 2013 and KOSPI-listed, makes prescription drugs like Growtropin, Stillen, and Bacchus.

DongKookPharmaceuticalCo.,Ltd.1 shared

KOSDAQ-listed comprehensive healthcare and pharmaceutical company behind the gum treatment Insadol and the wound-care ointment Madecassol.

SD BIOSENSOR INC.1 shared

KOSPI-listed in-vitro diagnostics company known for the STANDARD Q antigen/antibody test kits.

Sources and updates

Counts on this page are not company-reported figures. MAA matched records from DART, the Korean MFDS, the US FDA, ClinicalTrials.gov, PubMed and KIPRIS to this company itself, by business registration number or registered name, never by name similarity. They may differ from figures the company publishes.

Company basics
Korea Exchange · DART
Business content
Compiled from disclosure filings
Approvals & clinical trials
Korean MFDS (data.go.kr) · US FDA openFDA — updated weekly
Key disclosures
KRX KIND via OpenDART exchange filings — updated daily
Global clinical trials
ClinicalTrials.gov (US NIH) — sponsor-matched, updated weekly
Financials
DART corporate disclosure filings — annual
Publications
PubMed (US National Library of Medicine) — affiliation-matched, updated daily
Patents
KIPRIS (Korea Institute of Patent Information) — applicant-matched, updated monthly
AI reads
Our server logs, IP-verified every 6 hours
AI visibility
Measured 2026-10-01

This page is compiled from public sources without the company's involvement. If anything is inaccurate or incomplete, please let us know. Materials provided by the company are labelled as such.

Request a correction or addition